Psychedelic Clinical Trials
Find clinical trials studying psilocybin, MDMA, ketamine and other psychedelics. Many trials are actively recruiting participants who haven't found relief from conventional treatments.
Ketamine for OUD and Comorbid Depression (OUDCD)
University of Maryland, Baltimore
Reducing Adolescent Suicide Risk: Safety, Efficacy, and Connectome Phenotypes of Intravenous Ketamine
Yale University
KAP for Depression in Abstinent Opioid Users
Medical University of South Carolina
Effect of Ketamine on Neurological Activity as Measured by Electroencephalogram (EEG)
Entheon Biomedical Corp.
Study Comparing Two Versus Three Active MDMA-assisted Sessions in U.S. Military Veterans With Chronic PTSD
Lykos Therapeutics
Vital Capacity in Ultrasound Guided Serratus Plane Block in ED Patients With Multiple Rib Fractures
Antonios Likourezos
Visual Surround Suppression and Perceptual Expectation Under Psilocybin
University of Minnesota
Phase 1b Study in Patients With Short-Lasting Unilateral Neuralgiform Headache Attacks (SUNHA)
Beckley Psytech Limited
Severe Acute Respiratory Syndrome Coronavirus Type 2 (SARS-CoV-2)-Related Multiple Sclerosis (MS) Vaccination Study
Biogen
Ketamine in Veterans With Gulf War Illness
Baylor College of Medicine
The Effects of Low Dose Ketamine on Cardiovascular Function
University of Texas Southwestern Medical Center
ESKETamine for FIBromyalgia Treatment
Grand Hôpital de Charleroi
AnaConDa-therapy in COVID-19 Patients
Jeroen Bosch Ziekenhuis
PVB vs Ketamine/Lidocaine in Rib Fracture Patients
George Washington University
PSIL201 Long-term Follow-up Study: Psilocybin or Niacin / Major Depressive Disorder
Usona Institute
Study of Immunomodulation Using Naltrexone and Ketamine for COVID-19
Corewell Health East
Prophylactic Effects of Psilocybin on Chronic Cluster Headache
Gitte Moos Knudsen
Perioperative Analgesia on Postoperative Opioid Usage and Pain Control in H&N Cancer Surgery
Case Comprehensive Cancer Center
Initiating Ketamine in Acutely Suicidal Patients in the Emergency Department
Naval Medical Center Camp Lejeune
Efficacy of Magnetic Resonance-guided High Intensity Focused Ultrasound for the Ablation of Breast Cancer
Kantonsspital Winterthur KSW
Ketamine Interleaved With Electroconvulsive Therapy for Depression
St Patrick's Hospital, Ireland
Ketamine + Cognitive Training for Suicidality in the Medical Setting: Pilot
Rebecca Price
Intranasal Ketamine for Pain Control in Patients with Sickle Cell Disease and Vaso-occlusive Episode (VOE) in the PED
Abigail Nixon
Perioperative Ketamine in Opioid-Tolerant Patients Undergoing Lumbar Spine Surgery
Jacques E. Chelly
Sub-Dissociative Ketamine and Fentanyl to Treat Moderate to Severe Pain
Mercy Health Ohio
Intranasal Versus Intravenous Ketamine for Procedural Sedation in Children With Non-operative Fractures
University of Alabama at Birmingham
Avoiding Neuromuscular Blockers to Reduce Complications
Beth Israel Deaconess Medical Center
Ketamine for Severe Adolescent Depression: Intermediate-term Safety and Efficacy
Yale University
The Role of HNKs in the Antidepressant Effect of Ketamine
Columbia University
Ketamine for Pain in the Emergency Department
Hackensack Meridian Health
Effects of Psilocybin in Concussion Headache
Yale University
Efficacy And Tolerability Of Sub-Anesthetic Ketamine In Postpartum Depression
The University of Texas Health Science Center, Houston
Fecal Microbiota Transplantation (FMT) of FMP30 in Relapsing-Remitting Multiple Sclerosis
Jeffrey Gelfand
Acute Pain Management in Patients on Opioid Replacement Therapy
University of California, San Francisco
IN Ketamine vs IN Midazolam and Fentanyl for Laceration Repair
Corewell Health East
Paravertebral Nerve Blocks in Neonates
Emory University
Ketamine in Borderline Personality Disorder
Yale University
RCT: Fentanyl Plus Ketamine Versus Fentanyl Alone for Acute Burn Pain
Johns Hopkins University
Intravenous Subdissociative-dose Ketamine Versus Morphine for Prehospital Analgesia
Nantes University Hospital
Techniques to Reduce the Severity and Frequency of Emergent Reactions
CHRISTUS Health
Efficacy and Safety of BIIB033 (Opicinumab) as an Add-on Therapy to Disease-Modifying Therapies (DMTs) in Relapsing Multiple Sclerosis (MS)
Biogen
A Study to Evaluate Efficacy, Safety, and Tolerability of Alemtuzumab in Pediatric Patients With RRMS With Disease Activity on Prior DMT
Genzyme, a Sanofi Company
Intranasal Ketamine for Pediatric Procedural Sedation: a Feasibility Study
University of Arizona
Intraoperative Methadone Administration for Improved Pain Control in Spinal Fusion Patients
Montefiore Medical Center
Ketamine and Magnesium in Post-operative Pain Control in Patients Treated With Opioids
Milton S. Hershey Medical Center
Antipruritic Effect of Topical Ketamine, Amitriptyline, and Lidocaine
Gil Yosipovitch
Preventing pAIn With NMDA Antagonists - Steroids in Thoracoscopic lObectomy Procedures (PAIN-STOP) Pilot Trial
Population Health Research Institute
Fingolimod Versus Dimethyl-fumarate in Multiple Sclerosis
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Browse by Condition
View all conditions →How to Join a Clinical Trial
Clinical trials are research studies that test new treatments. Participating can give you access to cutting-edge therapies while contributing to medical science. Each trial has specific eligibility criteria based on the research goals.
1. Review
Read the trial details, eligibility criteria, and what participation involves.
2. Contact
Reach out to the study team using the contact information provided.
3. Screen
Complete the screening process to determine if you're eligible.